You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,809,305


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,809,305
Title:Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
Abstract: A regimen for the safe and effective long-term treatment of acne vulgaris entails topically applying onto the affected skin area of a subject afflicted therewith, for a period of time of at least four (4) months, e.g., for at least twelve (12) months and advantageously on a daily basis and preferably once a day, a thus effective amount of a topical medicament containing adapalene and benzoyl peroxide, formulated into a pharmaceutically acceptable medium therefor.
Inventor(s): Graeber; Michael (Lawrenceville, NJ), Liu; Yin (Princeton Junction, NJ), Gore; Barbara (Cranbury, NJ)
Assignee: Galderma Research & Development (Biot, FR)
Application Number:12/458,982
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,809,305
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

United States Patent 8,809,305: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 8,809,305, hereafter referred to as the '305 Patent, is a significant intellectual property asset in the pharmaceutical sector. This patent has been at the center of several legal disputes, particularly in the context of generic drug approvals and patent infringement cases. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

The '305 Patent is associated with a pharmaceutical product and has been the subject of litigation involving generic drug manufacturers. The patent covers specific claims related to the composition, use, and manufacturing process of the drug in question[2].

Claims of the '305 Patent

The claims of the '305 Patent are crucial in defining its scope and determining potential infringement. Here are some key aspects:

  • Infringement Allegations: The patent holders have alleged that the use and commercialization of certain generic products infringe on one or more claims of the '305 Patent. This includes the manufacture, sale, and importation of these products prior to the patent's expiration[2].
  • Claim Specificity: The claims typically include detailed descriptions of the drug's composition, its method of use, and any specific manufacturing processes. These claims are designed to be precise to protect the intellectual property while allowing for some flexibility in implementation[3].

Scope of the '305 Patent

The scope of a patent is determined by its claims and is a critical factor in patent litigation.

  • Independent Claim Length and Count: Research suggests that the scope of a patent can be measured by metrics such as independent claim length and count. Narrower claims, as seen in the '305 Patent, are often associated with a higher probability of grant and shorter examination processes[3].
  • Patent Breadth: The breadth of a patent refers to how broadly its claims cover related inventions. The '305 Patent's claims are specific enough to protect the patented invention but not so broad as to encompass unrelated technologies[3].

Patent Landscape

Understanding the broader patent landscape is essential for navigating the complexities of intellectual property in the pharmaceutical industry.

  • Global Dossier and IP5 Offices: The '305 Patent is part of a larger global patent system, where tools like the Global Dossier provide access to related applications and dossier data from participating IP Offices. This facilitates a more integrated and harmonized approach to patent management[1].
  • Common Citation Document (CCD): The CCD application consolidates prior art citations from multiple offices, making it easier to visualize the patent family and related citations. This is particularly relevant for patents like the '305 Patent, which may have multiple family members and citations across different jurisdictions[1].

Litigation and Enforcement

The '305 Patent has been involved in several legal disputes, highlighting the importance of robust enforcement mechanisms.

  • Infringement Cases: The patent holders have taken legal action against generic manufacturers, alleging infringement based on the submission of Abbreviated New Drug Applications (ANDAs) and the commercialization of products that allegedly infringe on the patent's claims[2].
  • Permanent Injunctive Relief: In these cases, the patent holders have sought permanent injunctive relief to prevent further infringement, demonstrating the serious consequences of violating patent rights[2].

Patent Assignment and Ownership

Changes in ownership and assignments are critical aspects of patent management.

  • Patent Assignment Search: The USPTO provides tools for searching patent assignments, which is important for tracking changes in ownership and ensuring that all parties involved in litigation are correctly identified[1].

Public Access and Search Facilities

Public access to patent information is vital for transparency and innovation.

  • USPTO Public Search Facility: The USPTO offers public search facilities, including online databases, microfilm, and print resources, to help users access patent and trademark information. Trained staff are available to assist in complex searches[1].
  • Patent and Trademark Resource Centers (PTRCs): Local PTRCs provide additional resources and training in patent search techniques, which can be invaluable for inventors and businesses navigating the patent landscape[1].

Forward Citations and Patent Maintenance

The validity and maintenance of a patent are influenced by various factors, including forward citations.

  • Forward Citations: Research indicates that patents with narrower claims at publication tend to have higher forward citations, which can be an indicator of the patent's impact and relevance[3].
  • Patent Maintenance Payments: The maintenance of a patent involves periodic payments to the USPTO. Studies have shown that narrower claims are associated with higher probabilities of grant and lower maintenance costs[3].

Allowance Rates and Examination Process

The probability of a patent being granted and the efficiency of the examination process are crucial metrics.

  • Allowance Rates: The allowance rate for patent applications varies across different technology fields and entity types. For instance, applications from large firms tend to have higher allowance rates compared to those from small firms[4].
  • Examination Process: The examination process involves multiple stages, including first-action allowance rates and progenitor allowance rates. The complexity of this process can lead to continuations and serialized applications, which complicate the calculation of allowance rates[4].

Conclusion

The '305 Patent is a significant asset in the pharmaceutical industry, with its scope and claims carefully defined to protect the patented invention. Understanding the patent landscape, including global dossier services, common citation documents, and public search facilities, is crucial for navigating intellectual property disputes. The litigation history and enforcement mechanisms surrounding this patent highlight the importance of robust intellectual property protection.

Key Takeaways

  • Specific Claims: The '305 Patent's claims are specific and designed to protect the patented invention.
  • Litigation History: The patent has been involved in several infringement cases, emphasizing the need for strong enforcement.
  • Global Patent System: Tools like the Global Dossier and CCD facilitate a more integrated global patent system.
  • Public Access: Public search facilities and PTRCs provide essential resources for accessing patent information.
  • Allowance Rates: The probability of grant and maintenance costs are influenced by the breadth and specificity of patent claims.

FAQs

Q: What is the significance of the '305 Patent in the pharmaceutical industry? A: The '305 Patent is significant because it protects a specific pharmaceutical product and has been central to several high-profile infringement cases.

Q: How can one search for related patents and applications? A: One can use tools like the Global Dossier and Common Citation Document (CCD) to search for related patents and applications.

Q: What are the key metrics for measuring patent scope? A: Key metrics include independent claim length and count, which are associated with the probability of grant and the efficiency of the examination process.

Q: How do changes in ownership affect patent management? A: Changes in ownership must be tracked using tools like the Patent Assignment Search to ensure all parties are correctly identified in legal disputes.

Q: What resources are available for public access to patent information? A: The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) provide public access to patent and trademark information.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN: https://insight.rpxcorp.com/litigation_documents/11361121
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. What Is the Probability of Receiving a US Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. Pharmaceutical drugs covered by patent 8,809,305: https://www.drugpatentwatch.com/p/patent/8809305

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,809,305

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.